Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026

The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what’s been observed over a similar timeframe in prior years, according to BioPharma Dive data.

Continue reading →